Lucas, Kurt, Maes, Michael · Molecular neurobiology · 2013 · DOI
This review examines how a part of the immune system called TLR4 may trigger ongoing inflammation in several diseases, including ME/CFS. The authors discuss environmental factors (like air pollution and certain chemicals) that can activate TLR4, and they review several drugs and natural substances that might reduce this harmful inflammation by blocking TLR4 activation.
This study identifies TLR4 pathway dysregulation and oxidative stress as a potentially unifying mechanism in ME/CFS alongside other inflammatory conditions. Understanding common immune activation pathways may open therapeutic avenues targeting the root causes of ME/CFS rather than only symptoms.
This review does not provide evidence that TLR4 activation is the primary cause of ME/CFS, nor does it establish that any proposed therapeutic actually works in ME/CFS patients—it only identifies candidates for investigation. The study does not prove causation from environmental exposures to ME/CFS, only that such exposures can activate TLR4 in various contexts.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Lucas, Kurt & Maes, Michael (2013). Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.. Molecular neurobiology. https://doi.org/10.1007/s12035-013-8425-7
BibTeX
@article{mecfsatlas-lucas-2013-role-toll,
author = {Lucas, Kurt and Maes, Michael},
title = {Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway.},
journal = {Molecular neurobiology},
year = {2013},
doi = {10.1007/s12035-013-8425-7},
note = {PubMed: 23436141},
url = {https://www.mecfsatlas.com/evidence/lucas-2013-role-toll},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-30. https://www.mecfsatlas.com/evidence/lucas-2013-role-toll
Contribute
Private, reviewed by a human. Not a public comment thread.